It's All About/Research Funding/San Jose/Type None Diabetes
JDRF is the only organization with a strategic research plan to end T1D. Our strategies include: Artificial Pancreas Systems Artificial pancreas systems will eliminate blood glucose testing and carb counting by totally automating insulin dosing, initially preventing dangerous low blood sugars and eventually ensuring ideal glucose control. Complications JDRF’s complications research is leading to therapies to treat and even reverse some of the debilitating, costly, and life-threatening complications caused by T1D. Encapsulation JDRF’s encapsulation research will restore insulin independence for 18 months to two years
by implanting newly created beta cells into a protective capsule, which eliminates the need for toxic immune suppression therapies. Health Care & Social Assistance sector comprises firms providing health care and social assistance for individuals. The sector includes both health care and social assistance because it is sometimes difficult to distinguish between the boundaries of these two activities. The industries in this sector are arranged on a continuum starting with providing medical care exclusively, continuing with those providing health care and social assistance and finally finishing with only social assistance. The services provided in this sector are delivered by trained health practitioners and social workers with requisite experience. San Jose’s Japantown (Nihonmachi) developed from where the immigrant Japanese first settled in Santa Clara Valley. More than a century following its humble beginnings, it remains one of the last three historical Japantowns in the United States. Around 1890, the Japanese came to the Santa Clara Valley because of the abundant farm work. Without an established community of their own, these Issei (first generation) pioneers found refuge in San Jose’s Chinatown (called “Heinlenville” by locals after John Heinlen, the man who built it) located north of the downtown area. As an Asian town center, Chinatown offered familiar lodging, entertainment, restaurants and shops providing comfort and safety from prevailing anti-Asian racism. By the early 20th century, the Japanese established their own community that flourished alongside Chinatown. Now, they could find cultural support, employment, goods, shelter and a social life that were uniquely Japanese. At first, Nihonmachi mostly served the bachelor migrant workers and Japanese farmers who came into town for supplies. See full list of Media Credits http://broadcaster.beazil.net/public/credits/youtube/videos/42022 People with T1D would never benefit from JDRF-funded innovations without our donors. The work to create transformational therapies to help people live with T1D cannot—and must not—be allowed to stop because dedicated researchers lack funds. Laboratory studies that are unlocking the mysteries of T1D and accelerating progress toward a cure and prevention must continue. With the generous help of supporters like you, JDRF is pursuing a diversified, dynamic research agenda that is moving us ever closer to a world without T1D.
If you live with T1D, you spend a lot of time thinking about your blood-sugar levels now and worrying about the complications that T1D may one day bring. You don’t want anyone else you love to ever know the physical, emotional and financial toll this disease takes. You want a cure. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
A number of key issues arise from the mentioned above. For instance:
sugar diabetes,tolazamide,Casual Plasma Glucose Test,Diabetes Complications,NIDDM,IGT,ACCORD Study,insulin pumps,no insulin production,prevention,grassroots fundraising,GLP-1 agonists,turn Type One into Type Now,mean glucose,make a donation,engage,NDEP,Beta Cell Regeneration,blood glucose meter,Immune System,sugar breakdown,T1D Team,Non-Profit Foundation,Medical Research Council,CGM,blood glucose monitoring,World without T1D,Recipe Swap,care delivery systems,life-changing breakthroughs,monogenic diabetes syndrome,leading global organization,diabetes care,Juvenile Diabetes Research Foundation,Online Diabetes Support Team,fasting plasma glucose,Microvascular Complications,contribute,diabetes diagnosis,EDIC Study,Translating Research Into Action for Diabetes.